Panlong Pharmaceutical: Announcement on Cancellation of Partial Raised Fund Accounts
Securities code: 002864 Securities abbreviation: Panlong Pharmaceutical Announcement number: 2026-005
Shaanxi Panlong Pharmaceutical Group Co., Ltd.
Announcement on Cancellation of Partial Raised Fund Accounts
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Basic situation of raised funds
As approved by the China Securities Regulatory Commission's Securities Regulatory Commission [2023] No. 1709 document, the company issued 9,352,740 RMB ordinary shares (A shares) to specific targets on September 19, 2023. The issue price was RMB 32.29 per share, and the total amount raised was RMB 301,999,974.60. Yuan 139,085,300.00 yuan has been remitted by Zhongtai Securities Co., Ltd. to the company's bank account opened at the Xi'an Software Park Branch of Bank of China Co., Ltd. with the account number 103307746042 on September 27, 2023; the bank account opened at the Xi'an Bank Xiangyang Branch with the account number 382011580000047922 114,000,000.00 yuan; a bank account opened at Xi'an Qujiang Branch of China Merchants Bank Co., Ltd. with the account number 129907180410960: 44,168,675.18 yuan; a total of RMB 297,253,975.18 was remitted. RMB 4,745,999.42 (after deducting the underwriter's underwriting fees and a total of RMB 4,477,357.94 excluding tax), deducting other issuance expenses directly related to the issuance of equity securities excluding tax of RMB 2,686,324.43, the net amount of funds raised was RMB 294,836,292.23.
It has been verified by Shu Lun Pan Certified Public Accountants (Special General Partnership) and issued a capital verification report No. ZF11235 [2023] by Xinhuishebaozi.
2. Management of raised funds
In order to standardize the management and use of raised funds, improve the efficiency and effectiveness of fund use, and protect the rights and interests of investors, the company has formulated a "Raised Funds Management System" in accordance with the "Company Law of the People's Republic of China", the "Securities Law of the People's Republic of China", the "Supervision Rules for Funds Raised by Listed Companies", the "Shenzhen Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 1 - Standardized Operations of Main Board Listed Companies (Revised in 2025)" and other relevant laws, regulations and normative documents, combined with the company's actual situation, formulated a "Raised Funds Management System", and implemented special account storage management for raised funds.
The company and the sponsoring institutions Zhongtai Securities Co., Ltd. and Bank of China Co., Ltd. Xi'an High-tech Development Zone Branch, Bank of Xi'an Co., Ltd. Textile City Branch, and China Merchants Bank Co., Ltd. Xi'an Branch respectively signed the "Tripartite Supervision Agreement on Raised Funds" on October 19, 2023. There are no major differences between the three-party supervision agreement and the Shenzhen Stock Exchange Tripartite Supervision Agreement Template, and the company has strictly complied with it when using the raised funds.
As of the disclosure date of this announcement, the company's special account for raising funds by issuing stocks to specific objects is as follows: Raised funds special account opening bank Special account number Purpose of funds Account status Bank of China Xi'an Software Park Branch Used for the research and development of traditional Chinese medicine formula granules and Cancellation this time
103307746042
line industrialization projects
Bank of Xi'an Xiangyang Branch Used for high-barrier transdermal drug delivery system Normal
382011580000047922
R&D platform construction project
China Merchants Bank Xi'an Qujiang Branch 129907180410960 Used to supplement working capital Canceled
3. Cancellation of accounts raised this time
In view that the raised funds in account 103307746042 used for the "R&D and Industrialization Project of Traditional Chinese Medicine Formula Granules" have permanently replenished working capital, and the account balance is 0.00 yuan, the company completed the cancellation procedures on February 4, 2026. After the special account for raised funds is cancelled, the corresponding raised funds supervision agreement shall be terminated accordingly.
4. Documents for reference
- Bank account cancellation certificate.
Shaanxi Panlong Pharmaceutical Group Co., Ltd. Board of Directors
February 5, 2026